Horizon Therapeutics Director of Engineering Salaries in Hagerstown, MD
The average Horizon Therapeutics Director of Engineering in Hagerstown, MD earns an estimated $211,708 annually, which includes an estimated base salary of $176,093 with a $35,614 bonus. Horizon Therapeutics' Director of Engineering compensation is $24,331 more than the US average for a Director of Engineering. Director of Engineering salaries at Horizon Therapeutics in Hagerstown, MD can range from $90,000 - $540,000.
In Hagerstown, MD, The Engineering Department at Horizon Therapeutics earns $11,571 more on average than the Design Department.
Last updated 3 years ago.
- $176,093
- avg. base
- $35,614
- avg. bonus
Director of Engineering Salaries at Horizon Therapeutics
In Hagerstown, MD, Directors of Engineering earn $4,293 more than Directors of Engineering, and $26,280 less than Sales Engineers.
Compensation at Horizon Therapeutics by Department
In Hagerstown, MD, The Engineering Department averages $11,571 more than the Design Department, and $14,571 less than the Product Department
Director of Engineering Compensation by Gender (All Companies)
The average female Director of Engineering at companies similar size to Horizon Therapeutics reported making $193,623, while the average male Director of Engineering at similar sized companies reported making $208,619.
Director of Engineering Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Director of Engineering at companies similar size to Horizon Therapeutics reported making $212,479, while the average African American/Black Director of Engineering at similar sized companies reported making $174,750.
How Directors of Engineering at Horizon Therapeutics Rate Their Compensation
The majority of Directors of Engineering at Horizon Therapeutics believe they're compensated fairly. 100% of Directors of Engineering at Horizon Therapeutics say they receive annual bonuses, and the vast majority (78%) are satisfied with their benefits. See more compensation ratings at Horizon Therapeutics
